Search clinical trials for: BAY1101042

Total 4 results

Bayer

Completed

Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single Oral 10 mg BAY1101042 Tablet Dose in Men and Woman With Renal Impairment and in Healthy Subjects

Renal Impairment

Germany
Bayer

Completed

Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single and Multiple Oral BAY1101042 Tablet Doses in Healthy Male Subjects

Healthy Volunteer

Germany
Bayer

Active, not recruiting

Non-proliferative Diabetic Retinopathy Treated With Runcaciguat (NEON-NPDR)

Diabetic Retinopathy

United States, Czechia, Denmark, Portugal, Spain, United Kingdom, Netherlands, Bulgaria, Latvia, Slovakia, Germany, Poland, Romania, Switzerland
Bayer

Terminated

Study of the Influence of Liver Function on Blood Concentrations of Runcaciguat in Participants With Different Degrees of Liver Impairment

Chronic Kidney Disease

Germany

3

Subscribe